期刊文献+

心脏介入治疗后应用Boomerang^(TM)血管封堵器局部血管并发症的观察 被引量:2

Influence of BoomerangTM(Vascular Closure Device) on Local Vascular Complications of Patients Receiving Heart Intervention Treatment
下载PDF
导出
摘要 目的探讨心脏介入治疗患者应用BoomerangTM血管封堵器封堵股动脉后血管并发症的发生情况。方法选择心脏介入治疗后采用封堵器的病例60例为观察组,常规手工压迫止血75例为对照组,观察比较两组止血成功率及局部血管并发症。结果观察组全部封堵成功,发生小血肿1例,血管并发症发生率2%;对照组发生各种血管并发症共8例,发生率11%,观察组效果优于对照组(P<0.05)。结论BoomerangTM血管封堵器应用于心脏介入治疗后,封堵股动脉的止血成功率高,血管并发症发生率低,提高了患者的舒适度。 Objective To explore the occurrence of vascular complications after applying Boomerang^TM (vascular closure device) to block femoral artery. Methods 60 case of patients who were applied vascular closure device after heart intervention treatment were made into observation group and 75 who where applied manual methods for hemostasia were made into control group. The success rate and local vascular complications were observed and compared. Results In observation group, all were blocked successfully, little hemotoma was found in one case, and the rate of vascular complication was 2%. In control group, there were 8 cases of vascular complications, the occurrence rate was 11%. Effect in observation group was better than that in control group (P〈0.05). Conclusion After Boomerang^TM (vascular closure device) is applied after the heart intervention treatment, the success rate of hemostasia of femoral artery is high, the occurrence of vascular complications is low and the comfort degree of patient is improved.
出处 《护理学报》 2007年第11期48-49,共2页 Journal of Nursing(China)
关键词 血管封堵器 血管并发症 介入治疗 护理 vascular closure device vascular complication intervention treatment nursing
  • 相关文献

参考文献3

二级参考文献17

  • 1Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and Ⅱb/Ⅲa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol, 2002,40:78-83.
  • 2Sesana M, Vaghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol, 2000, 12: 395-399.
  • 3Silber S. 10 years of arterial closure devices: a critical analysis of their use after PTCA.Z Kardiol, 2000, 89: 383-389.
  • 4Chamberlin JR, Lardi AB, McKeever LS, et al. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv, 1999, 47: 143-147.
  • 5Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol, 2001, 13: 354-362.
  • 6Geary K, Landers JT, Fiore W, et al. Management of infected femoral closure devices. Cardiovasc Surg, 2002, 10: 161-163.
  • 7Smith TP, Cruz CP, Moursi MM, et al. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg, 2001, 182: 658-662.
  • 8Johanning JM, Franklin DP, Elmore JR, et al. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg, 2001, 34: 983-985.
  • 9Schrader R, Steinbacher S, Burger W, et al. Collagen application for sealing of arterialpuncture sites in comparison to pressure dressing:a randomized trial [ J ]. Cathet Cardiovasc Diagn, 1992,27(4):298-302.
  • 10Wong GC, Giugliano RP, Antman EM. Use of low-molecularweight heparins in the management of acute coronary artery syndromes and percutaneous coronary in the intervention[J]. JAMA, 2003,289(3) :331-342.

共引文献14

同被引文献27

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部